Nuclear Security & Deterrence Monitor Vol. 20 No. 48
Visit Archives | Return to Issue PDF
Visit Archives | Return to Issue PDF
Nuclear Security & Deterrence Monitor
Article 9 of 12
December 16, 2016
NNSA Awards $10M to SHINE for Medical Isotope Production
The Department of Energy’s semiautonomous National Nuclear Security Administration has awarded $10 million in Phase II funding to SHINE Medical Technologies as part of the agency’s program to promote a domestic supply of molybdenum-99 (mo-99).
The…
Partner Content